| |
Positive, n (%)
|
Negative, n (%)
|
p-value
|
|---|
|
Age
|
|
≤ 65 years
|
8 (50)
|
8 (50)
| |
|
> 65 years
|
8 (57)
|
6 (43)
|
0.834
|
|
Gender
|
|
Female
|
13 (52)
|
12 (48)
| |
|
Male
|
4 (80)
|
1 (20)
|
0.513
|
|
Karnofsky performance status
|
|
90–100%
|
8 (80)
|
2 (20)
| |
|
70–80%
|
8 (40)
|
12 (60)
|
0.023
|
|
UICC stage
|
|
III
|
15 (56)
|
12 (44)
| |
|
IV
|
1 (33)
|
2 (67)
|
0.447
|
|
T category
|
|
1–2
|
4 (67)
|
2 (33)
| |
|
3–4
|
12 (50)
|
12 (50)
|
0.073
|
|
N category
|
|
0–1
|
2 (67)
|
1 (33)
| |
|
2–3
|
14 (52)
|
13 (48)
|
0.402
|
|
Histology
|
|
Squamous cell carcinoma
|
9 (60)
|
6 (40)
| |
|
Non- Squamous cell carcinoma
|
7 (47)
|
8 (53)
|
0.864
|
|
Tobacco consumption (PY)
|
|
0
|
5 (63)
|
3 (38)
| |
|
20–40
|
3 (38)
|
5 (63)
| |
|
> 40
|
8 (57)
|
6 (43)
|
0.105
|
|
Grading
|
|
Moderately differentiated
|
1 (50)
|
1 (50)
| |
|
Poorly differentiated
|
14 (54)
|
12 (46)
| |
|
anaplastic
|
1 (50)
|
1 (50)
|
0.223
|
|
CD8+ TILs density
|
|
≤ 40%
|
5 (50)
|
5 (50)
| |
|
> 40%
|
10 (59)
|
7 (41)
|
0.020
|
